[
    {
        "molecule_name": "Melanocortin receptor-specific cyclic peptides",
        "protein_target_name": "Melanocortin receptor",
        "binding_metric": "Ki",
        "value": "nanomolar or subnanomolar",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Melanocortin receptor-specific cyclic peptides are reported with nanomolar or subnanomolar Ki values, for pharmaceutical development for many indications it is desired and necessary to optimize functionality, such as EC50 and Emax values, such that the peptides are agonists, preferably full agonists, more preferably potent full agonists, with nanomolar or subnanomolar EC50 values and Emax values as high as feasible, such as over about 80%, about 90% or at or over 100%.\n* Melanocortin receptor-specific peptides may be evaluated by a number of parameters, including binding affinities (typically Ki values reported in nM) and various functional measures, such as EC50 and Emax values."
    },
    {
        "molecule_name": "Melanocortin receptor-specific cyclic peptides",
        "protein_target_name": "Melanocortin receptor",
        "binding_metric": "EC50",
        "value": "nanomolar or subnanomolar",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Melanocortin receptor-specific cyclic peptides are reported with nanomolar or subnanomolar Ki values, for pharmaceutical development for many indications it is desired and necessary to optimize functionality, such as EC50 and Emax values, such that the peptides are agonists, preferably full agonists, more preferably potent full agonists, with nanomolar or subnanomolar EC50 values and Emax values as high as feasible, such as over about 80%, about 90% or at or over 100%.\n* Melanocortin receptor-specific peptides may be evaluated by a number of parameters, including binding affinities (typically Ki values reported in nM) and various functional measures, such as EC50 and Emax values."
    },
    {
        "molecule_name": "Melanocortin receptor-specific cyclic peptides",
        "protein_target_name": "Melanocortin receptor",
        "binding_metric": "Emax",
        "value": "over about 80%, about 90%, or at or over 100%",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Melanocortin receptor-specific cyclic peptides are reported with nanomolar or subnanomolar Ki values, for pharmaceutical development for many indications it is desired and necessary to optimize functionality, such as EC50 and Emax values, such that the peptides are agonists, preferably full agonists, more preferably potent full agonists, with nanomolar or subnanomolar EC50 values and Emax values as high as feasible, such as over about 80%, about 90% or at or over 100%.\n* Melanocortin receptor-specific peptides may be evaluated by a number of parameters, including binding affinities (typically Ki values reported in nM) and various functional measures, such as EC50 and Emax values."
    }
]